Ranbaxy Laboratories and Teva Pharmaceuticals settled claims that stated that the two drug makers unlawfully restricted competition. It was settled with the New York Attorney General. The two drug leaders will pay he New York state $300,000 and have agreed to refrain from similar agreements in the future. Shares of both companies went up on this news.

Share :